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The d-Opioid Receptor Affects Epidermal Homeostasis
via ERK-Dependent Inhibition of Transcription Factor
POU2F3
Christine Neumann1,2,5, Mei Bigliardi-Qi1,5, Christian Widmann3 and Paul L. Bigliardi1,4
Neuropeptides and their receptors are present in human skin, and their importance for cutaneous homeostasis
and during wound healing is increasingly appreciated. However, there is currently a lack of understanding of the
molecular mechanisms by which their signaling modulates keratinocyte function. Here, we show that d-opioid
receptor (DOPr) activation inhibits proliferation of human keratinocytes, resulting in decreased epidermal
thickness in an organotypic skin model. DOPr signaling markedly delayed induction of keratin intermediate
filament (KRT10) during in vitro differentiation and abolished its induction in the organotypic skin model. This
was accompanied by deregulation of involucrin (IVL), loricrin, and filaggrin. Analysis of the transcription factor
POU2F3, which is involved in regulation of KRT10, IVL, and profilaggrin expression, revealed a DOPr-mediated
extracellular signal-regulated kinase (ERK)-dependent downregulation of this factor. We propose that DOPr
signaling specifically activates the ERK 1/2 mitogen-activated protein kinase pathway to regulate keratinocyte
functions. Complementing our earlier studies in DOPr-deficient mice, these data suggest that DOPr activation in
human keratinocytes profoundly influences epidermal morphogenesis and homeostasis.
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INTRODUCTION
The epidermis is a stratified epithelium constantly undergoing
self-renewal, which is temporally and spatially coordinated by
the balanced expression of genes regulating proliferation and
differentiation of keratinocytes, the main cell type present
(Blanpain and Fuchs, 2009). The transition of basal keratino-
cytes toward the spinous layer is accompanied by repression
of the synthesis of intermediate filament proteins keratin 5
(KRT5) and KRT14 (Fuchs and Green, 1980) and the
upregulation of early differentiation markers KRT1 and
KRT10. Differentiation toward the granular layer involves
upregulation of cornified envelope precursor proteins such as
involucrin (IVL) and loricrin (LOR), as well as filaggrin (FLG).
This sequence of epidermal gene regulation required for
appropriate differentiation of keratinocytes is regulated by
several transcription factors, including POU domain, class 2,
transcription factor 3 (POU2F3, also known as Skn-1, Epoc-1,
and Oct-11). POU2F3 belongs to a family of POU domain
transcription factors, which are preferentially expressed in
specific epidermal layers and are involved in regulation of
multiple keratinocyte differentiation genes. POU2F3 protein
seems to be expressed throughout all epidermal layers with
highest expression in the suprabasal layers (Andersen et al.,
1993; Goldsborough et al., 1993; Yukawa et al., 1993; Faus
et al., 1994; Andersen et al., 1997), and mice lacking POU2F3
express normal levels of KRT1 and KRT10 but show marked
abnormalities in KRT14 gene expression during wound
healing. POU2F3 gene expression is spatially regulated at
the wound front, corresponding to altered KRT1, LOR, FLG,
KRT14, and SPR1 gene expression, which suggests a role for
POU2F3 in facilitating reepithelialization at the wound front
(Andersen et al., 1997).
In view of the constant environmental assaults that the skin
must endure, such a delicate balance of gene expression might
easily become derailed in the absence of robust stabilizing
mechanisms. Recently, attention has focused on the local skin
neuroendocrine system as a potential player in regulating
epidermal differentiation. Expression of several neuro-
hormones, neurotransmitters, and neuropeptides, including
b-endorphin and enkephalins, has been shown in human skin
(Slominski et al., 2000; Slominski and Wortsman, 2000;
Bigliardi-Qi et al., 2000; Kauser et al., 2003; Bigliardi-Qi
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et al., 2004; Slominski et al., 2011, 2012, 2013). We
are particularly interested in the role of the receptor
for methionine5 (Met-) and leucine-enkephalin, the
d-opioid receptor (DOPr), in skin healing and homeo-
stasis (Bigliardi et al., 2009). Following specific activation at
the cell surface, the DOPr transmits the signal across the
membrane via an associated G-protein, leading to intracellular
signaling cascade activation. The DOPr can regulate
extracellular signal-regulated kinase (ERK) 1/2 activity (Burt
et al., 1996; Fukuda et al., 1996; Belcheva et al., 1998; Xu
et al., 2010), which has been linked to cell differentiation and
proliferation (Eckert et al., 2002; Shaul and Seger, 2007;
Gazel et al., 2008). Expression of the DOPr in murine and
cultured human skin has been documented, and mice lacking
the DOPr exhibit aberrant epidermal phenotypes and
delayed wound healing (Bigliardi-Qi et al., 2006). Although
the mechanisms underlying these phenotypes remain
unclear, the importance of the DOPr in these processes is
only now beginning to be appreciated: DOPr-deficient
mice exhibit markedly increased expression of KRT10,
alongside an atrophic epidermis, alluding to a role for DOPr
during stratification and skin homeostasis (Bigliardi-Qi et al.,
2006, 2009).
In this study, we sought to identify the molecular
consequences of DOPr activation in keratinocytes and to
understand how this influences skin differentiation and
homeostasis.
RESULTS
DOPr is expressed in suprabasal and granular layers of human
epidermis
We have previously documented the expression of DOPr
mRNA in cultured human keratinocytes (Bigliardi-Qi et al.,
2006, 2009), and have now gone on to confirm this expression
in vivo by in situ hybridization on human corporal skin
sections. Positive hybridization signals were detected in the
stratum granulosum and, to a lesser extent, in the stratum
spinosum. However, it was apparent that not all keratinocytes
express the same amount of DOPr, reflected in the
heterogeneous staining pattern (Figure 1a).
Further, to reliably identify the localization of the receptor,
a lentiviral overexpression system was used to introduce a
DOPr–green fluorescent protein (GFP) fusion protein into N/
TERT-1 keratinocytes. In low Ca2þ (0.09 mM) medium, DOPr
in cultured keratinocytes was almost completely localized in
intracellular compartments, with little expression at the cell
surface (Figure 1b—column 1). Upon shifting DOPr-over-
expressing keratinocytes to higher Ca2þconcentrations
(1.2 mM), the majority of DOPr translocated to the cell surface,
and a smaller fraction was detected in intracellular compart-
ments (Figure 1b—column 5). Within 1 hour of addition of
Ca2þ , the opioid receptor was found on the membrane,
despite the cells having not yet fully established des-
mosomal junctions, marked by desmoplakin labeling at areas
of cell–cell contact (Figure 1b—column 3). Eight hours after
addition of high Ca2þ , both desmosomal junction formation
and DOPr membrane localization had stabilized (Figure 1b—
column 4).
Overexpression and activation of the DOPr results in reduced
proliferation of keratinocytes
DOPr overexpression markedly changed the phenotype of
N/TERT-1 keratinocyte cultures. Colonies of DOPr-over-
expressing cells were more spread out than control cell
colonies and appeared to have reduced cell proliferation
rates. Although control cells entered an exponential growth
phase, before plateauing after about 6 days in culture, DOPr-
overexpressing cells showed markedly reduced proliferation
(Figure 2a). The addition of the DOPr ligand SNC80 signifi-
cantly and specifically reduced the level of confluence of
DOPr-overexpressing cell cultures (Figure 2b).
DOPr activation alters keratinocyte differentiation
We further went on to analyze the changes in expression of
KRT10 and KRT1 in an in vitro model of keratinocyte
differentiation using N/TERT-1 keratinocytes (Dickson et al.,
2000). Cells were grown to confluence before differentiation
was induced by growth factor withdrawal for up to 10 days in
the presence of the DOPr peptide agonist Met-enkephalin.
Quantitative real-time PCR analysis of mRNA levels demon-
strated that continued differentiation was associated with
56- (KRT10) and 114-fold (KRT1) upregulation of these
transcripts in control cells, whereas DOPr-overexpressing
cells exhibited significantly lower inductions; just 4- (KRT10)
and 13-fold (KRT1) increases were observed (Figures 3a
and b). With advancing differentiation, the mRNA levels of
the cornified envelope precursor proteins, IVL, LOR, and FLG,
increased markedly in control cells, but in DOPr-overexpres-
sing cells only at day 10 was a comparable increase in
expression of these genes detected (Figures 3c–e).
The delay in KRT1 and KRT10 induction during early
differentiation under the influence of DOPr signaling was
confirmed at the protein level. The increase in KRT1 and
KRT10 observed in control cells at day 4 and 7 of differentia-
tion was not detected in DOPr-activated cells in the presence
of the endogenous agonist Met-enkephalin (Figure 3f). When
DOPr-overexpressing cells were differentiated without addi-
tion of an agonist, a minor reduction in KRT10 protein
expression was also detected (Figure 3f, lanes 11–14). Similar
results were obtained using the exogenous DOPr agonist
SNC80 (Figure 3g, lanes 5–8), further illustrating the impor-
tance of the DOPr pathway irrespective of the ligand used to
stimulate signaling.
The transcription factor POU2F3 is involved in DOPr-mediated
regulation of differentiation
POU2F3 is one transcription factor involved in the transition
from basal to suprabasal keratinocyte phenotype (Lena et al.,
2010) and in the regulation of KRT10 and IVL expression
(Andersen et al., 1993; Welter et al., 1996; Andersen et al.,
1997). Our observations in HaCaT cells (Supplementary
Figures S3a and S3c online), DOPr / mice, and activated
DOPr-overexpressing N/TERT-1 keratinocytes (Figure 4a) con-
firm these published reports. After 1 day of differentiation,
DOPr activation by Met-enkephalin was associated with a
1.3-fold downregulation of POU2F3 mRNA, whereas control
cells induced POU2F3 transcription 1.5-fold. The relative
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mRNA expression level of POU2F3 at day 7 was only ninefold
greater in DOPr-overexpressing cells but increased 23-fold in
control cells (Figure 4a). POU2F3 regulation, thus, appeared
to be DOPr specific. Accordingly, during 24 hours of incuba-
tion, POU2F3 inhibition could be reversed by naltrindole,
resulting in similar expression levels in control and DOPr-
overexpressing cells (Figure 4b).
To test whether the regulation of POU2F3 was mediated
by ERK activation, we blocked the activation of ERK. Incuba-
tion with 20mM of the mitogen-activated protein kinase/ERK
kinase 1 (MEK 1) inhibitor PD98059 revealed a strong
correlation between POU2F3 expression and ERK 1/2 activity.
In DOPr-overexpressing cells, PD98059 abolished POU2F3
repression induced by either Met-enkephalin or SNC80
(Figure 4c; Supplementary Figure S4c online). The complete
inhibition of ERK 1/2 mitogen-activated protein kinase signal-
ing induced POU2F3 mRNA expression in both control and
DOPr-overexpressing cells, indicating the regulation of a
POU2F3 repressor by activated ERK 1/2.
DOPr impairs stratification and homeostasis in a reconstructed
epidermis model
To further investigate the influence of DOPr on epidermal
regeneration and homeostasis, we generated reconstructed
skin with features of epidermal differentiation and morphogenesis
using organotypic skin cultures (Bell et al., 1983; Stark et al.,
1999). DOPr-overexpressing N/TERT-1 cells, in contrast to
control cells, exhibited a poor capacity to form a fully
differentiated epidermis (Figures 5a and c). The previously
observed slow proliferation rate of DOPr-overexpressing
keratinocytes (Figure 2b) correlated with an atrophic (thinner)
epidermis in organotypic cultures. Quantification of the
epidermal area generated during stratification showed signifi-
cantly lower epidermal thickness in DOPr-overexpressing
cultures compared with controls (Figure 5b). Immunofluores-
cence analysis of KRT10 revealed the absence of this
early differentiation marker in DOPr-overexpressing cells
(Figure 5c), indicating an impairment of epidermal differentia-
tion as observed in the keratinocyte monolayer differentiation
experiments (Figures 3a and f). Although only two to three cell
layers were present, and despite the absence of KRT10, slight
expression of IVL was detected in DOPr-overexpressing
organotypic cultures (Figure 5c). Accordingly, proliferating
cell nuclear antigen could not be detected in DOPr-over-
expressing cells but was present in control cultures (Figure 5e).
No increase in the number of TUNEL-positive cells was
observed under DOPr overexpression, indicating that the
epidermal atrophy was not linked to apoptosis (Figure 5f)
but more likely to the decreased proliferation rate evidenced
in Figure 2.
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Figure 1. d-Opioid receptor (DOPr) is primarily expressed in suprabasal layers of normal human skin and exhibits Ca2þ -dependent membrane localization
in vitro. (a) In situ hybridization with digoxygenin-labeled antisense riboprobes showed prominent DOPr mRNA expression in spinous and granular layer
keratinocytes (arrows) of normal human epidermis. Basal, sporadically, suprabasal layer keratinocytes (asterisk) express DOPr at lower levels. Bar ¼ 50mm.
(b) Confocal fluorescence image stacks of DOPr (green) and desmoplakin (red) were obtained at 0.1mm intervals in Z-section. Nuclei are counterstained with
Hoechst (blue). N/TERT-1 cells overexpressing C-terminal green fluorescent protein (GFP)-tagged DOPr cultured in 0.09 mM Ca2þ medium exhibit an almost
complete loss of desmosomal junctions while DOPr gets internalized (column 1). After change to 1.2 mM Ca2þ medium desmosomes gradually reform. DOPr
starts to translocate to the membrane 15 minutes after Ca2þ addition and concentrates at the cell–cell junctions with progressive desmosome maturation. Bar ¼
10mm.
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We also confirmed the importance of the DOPr system in
fully differentiated human skin samples. Upon treatment with
SNC80 or Met-enkephalin for 7 days, we observed DOPr-
mediated epidermal overexpression of KRT10 and POU2F3,
which could be inhibited by the specific DOPr antagonist
naltrindole (Supplementary Figure S5 online). These data
clearly indicate a responsiveness of human skin to DOPr
stimulation and warrant more detailed investigation to refine
our knowledge of its likely physiological role.
DISCUSSION
The presence of opioid receptors in human skin has been
known for years. Their function in epidermal proliferation and
differentiation is only just beginning to be understood. We
show here that the DOPr is predominantly expressed in the
more differentiated layers of the human epidermis, which
correlates well with the expression of the endogenous ligand
enkephalin (Slominski et al., 2011). This raises the question of
whether receptor activation triggers molecular signaling
mechanisms influencing the differentiation or activation state
of keratinocytes (Freedberg et al., 2001). From previous studies
in other overexpression systems––e.g., with HEK293 cells––it
is known that DOPr activation is capable of causing down-
stream mitogen-activated protein kinase signaling and especially
ERK 1/2 phosphorylation and activation (Fryer et al., 2001;
Audet et al., 2005; Eisinger and Ammer, 2008a,b;2009). But
different cell types may vary in their availability of down-
stream molecules and might then experience a different
outcome following DOPr activation (Chen et al., 2006;
Gross et al., 2006; Shahabi et al., 2006).
The current study confirms that both, the endogenous DOPr
peptide agonist Met-enkephalin and the synthetic DOPr
alkaloid ligand SNC80, mediate a transient ERK 1/2 mito-
gen-activated protein kinase activation in different keratino-
cyte cell lines with DOPr overexpression (Supplementary
Figures S1 and S2 online). As well as activating DOPr
homomers, SNC80 can also activate heteromers of m-opioid
receptor and DOPr and induce potent downstream signaling
(Metcalf et al., 2012);however, the extent of DOPr
overexpression in our system effectively shifts the
equilibrium toward DOPr homomer formation and renders it
unlikely that heteromer signaling upon SNC80 binding
contributes to the effects seen (Law et al., 2005). Moreover,
despite this, and the differing affinities of the natural and
synthetic DOPr ligands used, a conserved pattern of response
is observed in DOPr-overexpressing cells. DOPr-mediated
signaling in undifferentiated keratinocytes in monolayer
tissue culture not only inhibits proliferation but also impairs
differentiation, leading to a deregulation of the epidermal
stratification process. The abundant expression of the DOPr in
the suprabasal layers correlates well with the knowledge that
these cells, in contrast to those in the basal layer, have a low
proliferative potential. During normal skin homeostasis, the
DOPr could interfere at the transition from spinous to granular
layer keratinocytes, where KRT10 expression is downregu-
lated. This is consistent with the observation that the
expression pattern of DOPr in non-wounded skin (Figure 1a)
partially correlates with the repression of KRT10 on mRNA
level (Roop, 1987). In monolayer cultures, a tendency toward
higher IVL expression in DOPr-overexpressing cells under
basal growth conditions was observed, which might partially
reflect this transition process. DOPr activation and signaling in
undifferentiated keratinocytes might be more harmful than
helpful. Our monolayer keratinocyte culture represented basal
layer epidermal conditions and might not reflect the actual
state of a keratinocyte expressing functional DOPr, and the
time frame of DOPr expression during differentiation is not
necessarily the same as found in the skin culture models. Of
note, this cannot be mimicked in 2D cell cultures. Because of
the deregulated early differentiation phase in DOPr-over-
expressing N/TERT-1 cells, subsequent differentiation
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Figure 2. d-Opioid receptor (DOPr) overexpression inhibits keratinocyte
proliferation. (a) Proliferation curves of DOPr-overexpressing and control cells,
in either vehicle control medium (0.001% DMSO) or 100 nM SNC80-
containing medium, were obtained from the images captured hourly with
a 10x objective lens by the Incucyte machine. The graph depicts the
meanþ / SEM percentage confluence per field of view of a representative
experiment (n¼3 per culture condition). Phase-contrast images of control and
DOPr-overexpressing N/TERT-1 cultures were captured at 20x magnification,
5 days after plating the same amount of N/TERT-1 cells into standard culture
vessels. Bar ¼ 20mm. (b) The percentage confluence after 5 days (120 hours)
of culture is displayed as mean þ / SEM of three independent experiments.
One-way ANOVA with the Newman-Keuls post hoc test, *Po0.05, **Po0.01.
GFP, green fluorescent protein.
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Figure 3. d-Opioid receptor (DOPr) overexpression and activation impairs keratinocyte differentiation. Cells were grown to confluence and differentiation
induced by removal of growth factors under the influence of methionine5 (Met)-enkephalin for up to 10 days. Differentiation marker gene expression was analyzed
by quantitative real-time PCR. Data are represented after normalization to RPL13a expression as mean±SEM (n¼ 3 keratin intermediate filament (KRT10), n¼ 4
KRT1, n¼5 involucrin (IVL), loricrin (LOR), and filaggrin (FLG)). Expression levels of (a) KRT10, (b) KRT1, (c) IVL, (d) LOR, and (e) FLG are shown after
normalization to vehicle-treated control cells. Two-way analysis of variance, ***Po0.001, **Po0.01, and *Po0.05. (f, g) Whole-cell lysates from confluent
cultures (day 0) and day 1, 4, and 7 of differentiation with and without addition of 100 nM Met-enkephalin (f) or SNC80 (g) were analyzed by immunoblot for
KRT10 and KRT1 expression, with equal loading verified by glyceraldehyde-3-phosphate dehydrogenase (GAPDH). GFP, green fluorescent protein.
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Figure 4. POU domain, class 2, transcription factor 3 (POU2F3) is a target of d-opioid receptor (DOPr)-mediated signaling. Keratinocytes were grown to
confluence and differentiation induced by removal of growth factors. POU2F3 expression was analyzed by quantitative real-time PCR. Relative quantity is
represented after normalization to RPL13a and the respective vehicle control as reference. (a) POU2F3 expression under influence of methionine5 (Met)-
enkephalin during 7 days of differentiation. Graphs show mean±SEM (n¼ 5). Two-way analysis of variance, ***Po0.001. (b) Keratinocytes were differentiated for
24 hours in the presence of 100 nM Met-enkephalin, 100 nM SNC80, 10mM naltrindole, or vehicle control. Graph represents mean±SEM (n¼4). t-Test, *Po0.05.
(c) Keratinocytes were differentiated for 24 hours in the presence of 100 nM Met-enkephalin, 100 nM SNC80, 20mM of extracellular signal-regulated kinase (ERK)
inhibitor PD98059, or vehicle control. The graph represents mean ±SEM (n¼ 4). t-Test, *Po0.05 and ***Po0.001. GFP, green fluorescent protein.
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processes are altered in the 2D monolayer in vitro model.
According to the DOPr expression pattern in vivo, the early
phase might be executed normally, and DOPr only influences
subsequent processes during epidermal differentiation. Human
skin organ culture experiments with fully differentiated and
developed skin confirmed the regulation of KRT10 and
POU2F3 in intact epidermis (Supplementary Figure S5
online) and revealed the complex regulatory mechanism of
the opioid system in vivo. On the other hand, DOPr-deficient
mice showed increased expression of KRT10, which might
reflect the absence of the DOPr ‘‘off switch’’ during their
transition to the granular layer (Bigliardi-Qi et al., 2006).
Previous studies have suggested that POU2F3 is exclusively
expressed in the epidermis and acts as a bifunctional trans-
cription factor activating the expression of KRT10 and
small proline-rich protein 2A (Cabral et al., 2003), while
simultaneously repressing transcription of KRT14, IVL, and
profilaggrin (Welter et al., 1996; Jang et al., 2000; Sugihara
et al., 2001). The competition between the transcription factor
DNp63 and POU2F3 in the regulation of KRT10 and KRT14
expression was thereby suggested to act as a molecular switch
for differentiation (Lena et al., 2010). Our study indicates that
POU2F3 is a critical factor in the complex regulatory network
of differentiation. It was further suggested that POU2F3
enhances epidermal stratification by promoting keratinocyte
proliferation (Hildesheim et al., 2001). In agreement with
Hildesheim et al. (2001), we observed low proliferation and
reduced POU2F3 expression, accompanied by poor
stratification of DOPr-activated keratinocytes.
Andersen et al. (1997) reported that POU2F3-deficient mice
showed no obvious deviation from normal skin phenotype,
probably due to compensatory mechanisms, and therefore its
function was proposed to be more important for wound
healing. Wound edge keratinocytes are more migratory and
flexible compared with homeostatic keratinocytes in order to
efficiently close the wound. POU2F3 was suggested to be
repressed in these cells to enable this phenotype change, and
DOPr might be involved in this process. DOPr activity at the
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Figure 5. d-Opioid receptor (DOPr) activity results in decreased epidermal thickness and atypical stratification. Organotypic cultures of N/TERT-1 cells non-
transduced or transduced with control or DOPr-green fluorescent protein (GFP) lentivirus were generated. (a) Hematoxylin and eosin (H&E) staining sections of
organotypic raft cultures show decreased epidermal thickness when the DOPr was overexpressed. Bar ¼ 100mm. (b) Epidermal areas from H&E staining were
quantified and normalized to the respective wild-type (WT) control. Graph represents the mean±SD (n¼ 3) with duplicates per experimental condition. One-way
analysis of variance, *Po0.05. Tissue sections were labeled for differentiation markers (c) keratin intermediate filament (KRT10) and (d) involucrin (IVL) by
immunofluorescence. (e) Proliferating cell nuclear antigen (PCNA) immunofluorescence labeling marks proliferating cells in the basal layer of control, and (f) the
TUNEL assay shows only single apoptotic cells in both control and DOPr-overexpressing cultures. This correlates well with the atrophic phenotype. Nuclei were
counterstained with Hoechst. Bar¼ 50mm.
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wound edge could facilitate the phenotype change of kera-
tinocytes in order to promote the early reepithelialization
process (Andersen et al., 1997; Usui et al., 2005; Patel et al.,
2006). This observation is in line with the observations from
DOPr-deficient mice, which exhibit a delay in the wound
healing process with formation of hypertrophic wound edges
(Bigliardi-Qi et al., 2006). The wound edge keratinocytes in
these mice might not have undergone the necessary molecular
changes, such as DOPr-mediated downregulation of POU2F3,
in order to migrate properly and close the wound efficiently
(Bigliardi-Qi et al., 2006). Recently, POU2F3 downregulation
in superficial cutaneous wounds at day 3 of the wound healing
process in humans has been reported, which strongly supports
the data from our DOPr mouse models (Nuutila et al., 2012).
Further experiments are necessary to clarify the connection of
DOPr activity as well as POU2F3 regulation during wound
healing in humans. To our knowledge previously unreported,
our study indicates a connection between ERK signaling and
POU2F3 regulation. A possible transcription factor involved in
ERK-mediated repression of POU2F3 might be c-Myc. The
c-Myc protein is an important transcription regulator during
the reepithelialization process of wound healing (Tsuboi et al.,
1990; Zanet et al., 2005) and might therefore be involved in
the DOPr-mediated regulation of POU2F3 via ERK signaling.
Thus, this signaling cascade is more complex and likely
involves polycomb protein–mediated chromatin remodeling
(Brien et al., 2012). Therefore, possible epigenetic changes
occurring upon DOPr activation will need to be uncovered if
we are to fully understand this system.
The present study suggests that DOPr is expressed and
activated in a spatially and temporally controlled manner in
human skin cells. Deregulation would then be predicted to
lead to alterations in epidermal differentiation affecting skin
physiology and pathology, whereas the therapeutic applica-
tion of exogenous opioidergic drugs could prove invaluable to
facilitate wound healing if we could define the right target
cells, dose, and timing for treatment. This study represents the
beginning of the process of achieving the required level of
understanding. The DOPr-mediated molecular signaling
mechanism, to our knowledge previously unreported, observed
in both 2D and 3D culture models suggests that peripheral
opioids have an important role in controlling processes of skin
homeostasis, therefore contributing to the wound healing
process. This mechanism and the good correlation between
the mouse and human in vivo and in vitro system provide a
basis for future clinical interventions and applications using
opioid receptor ligands.
MATERIALS AND METHODS
Cell culture
N/TERT-1 (Dickson et al., 2000) cells, developed at Dr J. Rheinwald’s
laboratory (Harvard Medical School, Boston, MA), were cultured in
keratinocyte serum-free medium supplemented with 0.2 ng ml 1 EGF
and 25mg ml 1 bovine pituitary extract, grown to 50% confluence
at 37 1C and 5% CO2, and subcultured using TrypLE Express
(all purchased from Life Technologies, Singapore). HEK 293Ta
cells were cultured in DMEM containing 10% fetal bovine serum,
0.1 mM minimum essential medium nonessential amino acids (Life
Technologies), and penicillin/streptomycin. Differentiation was
induced by subjecting cells at 95–100% confluence to withdrawal
of growth factors (EGF, bovine pituitary extract).
Reagents
Antibodies used in this study were as follows: rabbit polyclonal anti-
GFP antibody (no. ab290, Abcam, Hong Kong); mouse monoclonal
anti-KRT10, clone DE-K10 (Ivanyi et al., 1989; no. ab9026, Abcam, or
no. MS-611, Thermo Fisher Scientific, Fremont, CA); mouse mono-
clonal anti-KRT1 antibody, clone 34bB4 (no. NCL-CK1, Novocastra,
New Castle Upon Tyne, UK); mouse monoclonal anti-IVL (Sy5, no.
MS-126, Thermo Fisher Scientific), rabbit anti-proliferating cell nuclear
antigen (FL-261, no. sc-7907, Santa Cruz Biotechnology, Heidelberg,
Germany), mouse monoclonal anti-desmoplakin, clone 11-5F (kindly
provided by D. Garrod, University of Manchester, UK (Parrish et al.,
1987)); and mouse monoclonal anti-glyceraldehyde-3-phosphate
dehydrogenase (3E8AD9, no. A21994, Life Technologies). Secondary
antibodies used were goat anti-mouse AlexaFluor 594, goat anti-rabbit
AlexaFluor 488, and goat anti-rabbit AlexaFluor 594 (Life
Technologies/Molecular Probes, Eugene, OR). Detection antibodies
used for western blotting were goat anti-mouse IRDye 800 and goat
anti-rabbit IRDye 700DX (Rockland, Gilbertsville, PA). SNC80 and
naltrindole were from Tocris Biosciences (Bristol, UK), PD98059 from
Promega (Madison, WI), and the solvent for SNC80 and PD98059,
DMSO, as well as Met-enkephalin from Sigma-Aldrich (Singapore).
DNA construct
The plasmid used for all N/TERT-1 experiments was a lentiviral
expression clone with pEZ-Lv122 vector backbone including the
DOPr-GFP open reading frame (NCBI entry U10504) purchased from
GeneCopoeia (no. EX-A1155-Lv122; Rockville, MD).
Lentivirus
For production of recombinant lentiviral particles HEK 293Ta cells
were transfected with 1.5mg of purified DOPr plasmid and 1mg of
each human lentiviral packaging vectors psPax, pMD2.G (Yang et al.,
2004) using Qiagen Effectene Transfection Reagent (Qiagen,
Singapore), according to the manufacturer’s instructions. Two days
after transfection virus-containing medium was harvested and
concentrated by ultracentrifugation at 22,000 rpm at 4 1C for
2 hours 16 minutes in a Beckman Coulter JS-24.38 rotor. Cells were
infected at 30% confluence with a multiplicity of infection of
approximately 10, in the presence of 10mg ml 1 Polybrene
(Millipore, Singapore). After 24 hours, the viral particle–containing
medium was replaced with fresh medium, and cells were cultured for
at least 48 hours before use.
RNA extraction and quantitative real-time PCR
Total RNA from cultured cells was isolated using the ‘‘RNeasy Mini
Kit’’ (Qiagen), according to the manufacturer’s instructions. A volume
of 1mg RNA was reverse-transcribed with the ‘‘PrimeScript RT reagent
Kit’’ (TaKaRa, Otsu, Shiga, Japan), according to the manufacturer’s
instructions. Quantitative PCR assays were carried out on a real-time
PCR detection system (7500 Fast Real-Time PCR System; Applied
Biosystems, Singapore) using the ‘‘QuantiFast SYBR Green PCR
Kit’’ (Qiagen). To evaluate the expression level of human KRT1,
KRT10, IVL, and POU2F3 mRNAs, commercially available Quanti-
Tect Primer Assays (Qiagen, no. QT00014182, QT00017045,
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QT00082586, and QT00029057) were used. Primers for LOR detec-
tion were: 50-TCATGATGCTACCCGAGGTTTG-30 and 50-CAGAAC
TAGATGCAGCCGGAGA-30 and for FLG: 50-GAAGACAAGGA
TCGCACCAC-30 and 50-ATGGTGTCCTGACCCTCTTG-30. RPL13a
expression was used for normalization. These primer sequences were
as follows: 50-CTCAAGGTCGTGCGTCTGAA-30 and 50-TGGCTGT
CACTGCCTGGTACT-30. Quantification was performed using the
comparative 2DDCT method.
Immunoblotting
Protein extracts were prepared by cell lysis in buffer containing
10 mM TRIS-HCL, 5 mM EDTA, 5 mM EGTA at pH 7.5, supplemented
with 4% SDS, 1% Triton X-100, 160 mM dithiothreitol, 0.8 mM
phenylmethylsulfonyl fluoride, 0.8 mM Na3VO4, and 1x protease
inhibitor (Roche, Singapore). Lysates were boiled for 5 minutes at
95 1C and subjected to SDS-PAGE. Proteins were transferred on to a
nitrocellulose membrane (BioRad, Mu¨nchen, Germany). For glycer-
aldehyde-3-phosphate dehydrogenase (1:8000), KRT10 (1:200), and
KRT1 (1:200) antibodies, blots were incubated in tris-buffered
saline containing 0.1% Tween-20 and 5% nonfat milk. After incuba-
tion with appropriate secondary antibody (1:5000), proteins
were visualized with the Odyssey infrared imaging system (LICOR
Biosciences, Lincoln, NE).
Immunolabeling and confocal microscopy
Cells were seeded on glass coverslips and subjected to treatments
indicated in the figures. Cells were fixed in 4% paraformaldehyde for
15 minutes at room temperature, permeabilized, and blocked using
0.3% Triton X-100 and 10% goat serum in phosphate-buffered saline.
Coverslips were incubated overnight at 4 1C with corresponding
primary antibodies (anti-GFP 1:900, anti-desmoplakin 1:100). A
1:300 dilution of labeled secondary antibodies was used; nuclei were
stained with 10mg ml 1 Hoechst 33258 (Sigma-Aldrich, no. B2883)
and mounted on to microscope slides (Fluorescence Mounting
Medium, Dako). Organotypic skin cultures were fixed in 10% neutral
buffered formalin. Paraffin embedding, sectioning, and hematoxylin
and eosin staining were conducted by the Institute of Molecular and
Cell Biology Core Histopathology Laboratory, Singapore. For immu-
nofluorescence labeling, deparaffinized sections underwent heat-
mediated antigen retrieval. After blocking, antibodies were added
and incubated overnight at 4 1C. Secondary antibody labeling,
counterstaining with Hoechst dye, and mounting were as above.
Confocal images were captured as z-stacks and projected to a single
image using an Olympus FV1000 microscope system with an
UPLFLN 40x/1.3 NA oil-immersion lens and UPLSAPO 20x/0.75
NA dry lens. Images were processed and exported using FV1000
Viewer application software (FV10-ASW, Olympus, Singapore).
Figures were assembled using Photoshop (CS3 Extended; Adobe,
Singapore).
In situ hybridization
The digoxigenin-labeled riboprobes were generated from the full-
length hDOPr clone in a pcDNA3 plasmid (a gift from B.L. Kieffer)
and hybridized as described in Bigliardi et al. (1998). The biopsies
were all taken from healthy individuals after donor approval at the
University of Basel in 1997 and were approved according to the local
ethical guidelines at that time. The use of surgical waste skin for skin
organ cultures (Supplementary Information) has been approved under
the NUS-IRB, Reference Code 13-25-IE of the University of Singa-
pore. The study was conducted according to the Declaration of
Helsinki Principles. Brightfield images were captured on a Nikon
Diaphot 300 microscope equipped with a digital CCD color camera
(CF 20 DXC, Kappa Messtechnik, Germany) using 10x/0.25 NA, 40x/
0.55 NA, and 60x/0.7 NA dry lenses.
Proliferation assay
A total of 1000 N/TERT-1 cells were plated into 96-well plates
and allowed to adhere overnight. Medium was changed to either
DMSO vehicle control medium or 100 nM SNC80-containing
medium, and the plate was placed into the Incucyte machine (Essen
BioScience, Ann Arbor, MI). Hourly images were captured with the
10x/1.49 NA objective lens. Using the metrics from the Incucyte
software, percentage confluence was determined.
Organotypic culture
A dermal equivalent was generated by preparing a gel containing rat
tail collagen type I (BD, no. 354236) and dermal fibroblasts (100,000
cells per ml) in a cell culture insert (pore size 1mm, BD, no. 353102).
Dermal equivalents were cultured in FAD medium: 3:1 mixture of
DMEM and Ham’s F12 nutrient mix (Life Technologies) supplemen-
ted with penicillin/streptomycin (PAA Laboratories GmbH, Germany),
10% fetal bovine serum (JR Scientific, Woodland, CA), 1% Glutamax
(Life Technologies), 0.4mg ml 1 Hydrocortisone (Sigma-Aldrich; no.
H0888), 5mg ml 1 Insulin (Sigma-Aldrich, no. I2643), 1.8 10 4 M
Adenine (Sigma-Aldrich; no. A2786), 10 ng ml 1 EGF (Sigma-
Aldrich, no. E9644), 5mg ml 1 Transferrin (Sigma-Aldrich, no.
T2036-1G), and 2 10 11 M 3,30,5-Triiodo-L-thyronine (T3; Sigma-
Aldrich, no. T6397). After 48 hours, N/TERT-1 cells (200,000 per
culture) were seeded on top of dermal equivalents and cultured under
submerged conditions until a confluent monolayer had developed.
Cultures were shifted to air–liquid interface, EGF supplementation
stopped, and cultures allowed to stratify for 14 days.
Quantification of the epidermal area from organotypic cultures
Hematoxylin and eosin-stained tissue sections were imaged using
an Ariol high-resolution fluorescence and brightfield slide scanner
(Leica Microsystems, Wetzlar, Germany) at the Institute of Molecular
and Cell Biology Core Histopathology Laboratory, Singapore. Using
ImageJ, a threshold was defined, and the remaining area of dark
hematoxylin and eosin staining representing the epidermis was
quantified. GFP control and DOPr-overexpressing cultures were
normalized to non-transduced wild-type controls and three indepen-
dent experiments combined for statistical analysis. A one-way
analysis of variance with the Newman-Keuls post hoc test was
performed to determine the P-value.
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